Population Pharmacokinetics and Pharmacodynamics with Enterohepatic Recirculation of Co-Medication of Rosuvastatin and Ezetimibe
Drug Design, Development and Therapy · 2025-06 · Volume 19 · 4777-4787
DOI: 10.2147/dddt.s522863 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2025-06. Verfasst von Hyungmi An und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics and Data Science, Korea National Open University, Seoul, Korea. Hauptthemen laut MEDLINE: Rosuvastatin Calcium, Ezetimibe, Anticholesteremic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Statistics and Data Science, Korea National Open University, Seoul, Korea.
- Department of Clinical Pharmacology and Therapeutics, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
ORCID-Profile: Hyungmi An, Dongseong Shin
Zitieren
APA
An, H., & Shin, D. (2025). Population Pharmacokinetics and Pharmacodynamics with Enterohepatic Recirculation of Co-Medication of Rosuvastatin and Ezetimibe. Drug Design, Development and Therapy, Volume 19, 4777-4787. https://doi.org/10.2147/dddt.s522863
Vancouver
An H, Shin D. Population Pharmacokinetics and Pharmacodynamics with Enterohepatic Recirculation of Co-Medication of Rosuvastatin and Ezetimibe. Drug Design, Development and Therapy. 2025;Volume 19:4777-4787. doi:10.2147/dddt.s522863
BibTeX
@article{An2025,
author = {An, Hyungmi and Shin, Dongseong},
title = {Population Pharmacokinetics and Pharmacodynamics with Enterohepatic Recirculation of Co-Medication of Rosuvastatin and Ezetimibe},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {4777--4787},
doi = {10.2147/dddt.s522863}
}
EUVIMED